In the Spotlight
The Polycystic Kidney Disease (PKD) Foundation Names Mount Sinai Health System Partner Clinic
The Polycystic Kidney Disease (PKD) Foundation—the only organization in the U.S. dedicated solely to finding treatments and a cure for PKD recently named Mount Sinai Health System as a PKDF Partner Clinic for their desire to support patients with Autosomal Dominant PKD (ADPKD). The PKDF Foundation has identified fifteen Partner Clinics around the country who will be partnered with clinicians at one of the Foundation’s Centers of Excellence to participate in a mentorship program to collaborate on providing specialized care to individuals with ADPKD.
"Humanizing" the Patient Experience
Dr. Peter Gliatto, Professor of Medicine (General Internal Medicine), discusses the biggest advantage of Mount Sinai’s Visiting Doctor Program: having the ability to give physicians more time with patients, which humanizes their health care experience.
"Many patients are homebound or can be economically disadvantaged and socially disadvantaged and that ties into social determinants of health, which is a much bigger emphasis in medical education these days.
So that's our goal, is to really have people pause when they're thinking through how to deliver healthcare." Peter Gliatto, MD
Kirk Campbell, MD Appointed President-Elect of National Kidney Foundation Board of Directors
Dr. Kirk Campbell, Professor of Medicine (Nephrology) was recently appointed President-elect of the National Kidney Foundation's board of directors. Congratulations on this well-deserved honor!
"I feel honored and fortunate to serve on the prestigious NKF Board of Directors as I continue to help advocate for the 37 million adults in the U.S. affected by kidney disease,” said Dr. Campbell. “There is much work to be done in improving diagnostic and therapeutic capabilities in kidney disease management while ensuring that appropriate resources reach individuals and communities most in need." - Kirk Campbell, MD
Strep Throat or COVID-19?
Dr. Matthew Weissman, Professor of Medicine (General Internal Medicine); and Site Chair of Medicine, Mount Sinai Beth Israel, discusses how to differentiate the symptoms of strep throat from those of COVID-19.
“The big problem with strep is that risk that if it’s untreated it can lead to other medical conditions, in particular rheumatic fever, which can cause all kinds of problems with your bones and joints and, most importantly, with your heart and heart valves. So really important, if it is strep, to get antibiotics and to finish the full course of the antibiotics.” - Matthew Weissman, MD, MBA
Does Fiber Worsen IBD Symptoms?
Dr. Stephanie Gold, Instructor (Gastroenterology), comments on the effects of dietary fiber among people with inflammatory bowel disease.
"As we are learning more about the benefits of fiber and how these indigestible carbohydrates interact with the microbiome through fermentation, we will need to identify which patients would benefit from increasing the fiber in the diet and which type of fiber is most beneficial as well as easily tolerated." - Stephanie Gold, MD
Alfred Burger, MD, MS, Appointed Scholar in the American Medical Association’s Health System Science Scholars Program
Dr. Alfred Burger, Professor of Medicine (Hospital Medicine), and Senior Associate Program Director for the Mount Sinai Beth Israel Internal Medicine Residency, will be serving as a scholar in the AMA Health Systems Science (HSS) Scholars Program. This is an initiative of the American Medical Association (AMA) Accelerating Change in Medical Education Consortium. The purpose of the HSS Scholars Program is to equip faculty who have significant responsibility for—or who anticipate having responsibility for—implementing and/or teaching topics related to health systems science, with the knowledge and skills needed to be outstanding teachers and leaders.
The Dangers of Mixing Antibiotics with Alcohol
Dr. Scott Friedman, Professor of Medicine; and System Chief, Division of Liver Diseases, discusses the dangers of taking antibiotics with alcohol.
“Alcohol can change both the absorption and breakdown of antibiotics by the liver, making them less available in the body to treat the underlying infection for which they are being used". - Scott Friedman, MD
First US patient Enrolled in Abivax’s Phase 3 Trial of Obefazimod for Ulcerative Colitis
Dr. Bruce Sands, Professor of Medicine; and System Chief, Division of Gastroenterology, discusses the announcement from biotechnology company Abivax that the first U.S. patient has been enrolled in the ABTECT program, a global phase 3 clinical trial of its oral small-molecule inhibitor obefazimod for the treatment of moderate-to-severe ulcerative colitis.
"As a practicing gastroenterologist, I am confronted every day with the high unmet medical need for safe therapies that have long-term efficacy and convenient administration for patients with ulcerative colitis." - Bruce Sands, MD
Becker's Hospital Review: 10th Annual CEO + CFO Roundtable
Dr. Charles Powell, Professor of Medicine; and System Chief, Division of Pulmonary, Critical Care and Sleep Medicine, was asked to join a panel of experts in Chicago to discuss the clinical service lines that should be focused on or implemented at medical institutions.
"Initiatives that leverage innovation is our implementation of an enterprise cellular network-based remote monitoring program for patients with advanced airway disease. Another example is our ongoing machine learning and artificial intelligence research program that builds on our institution's large data ecosystem to advance diagnostics and treatment of simple and complex respiratory diseases." - Charles Powell, MD
The Importance of Gender-Affirming Care for Youth
Dr. Joshua Safer, Professor of Medicine (Endocrinology, Diabetes, and Bone Disease), was featured on the Apple TV show The Problem with Jon Stewart, to discuss the importance of providing gender-affirming care for youth, to prevent depression and suicide exacerbated by transgender youth being not affirmed.
Augusto Villanueva, MD Discusses Risk Factors for HCC in the Hispanic Community
Dr. Augusto Villanueva, Associate Professor of Medicine (Liver Diseases), discusses what to know about liver cancer and how it effects the Latino community, as the rates of liver cancer incidence for Latinos are 73 percent higher than for the White population.